What is the classification and diagnosis of a stroke according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The TOAST classification system is used to categorize ischemic strokes into five subtypes: large-artery atherosclerosis, cardioembolism, small-vessel occlusion (lacunar), stroke of other determined etiology, and stroke of undetermined etiology, which is crucial for guiding treatment and secondary prevention strategies. The classification of a stroke according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) is based on clinical features, brain imaging, cardiac evaluation, and vascular studies.

Key Points

  • The TOAST classification system is essential for determining the underlying cause of a stroke and guiding appropriate treatment.
  • The five subtypes of ischemic strokes are:
    • Large-artery atherosclerosis
    • Cardioembolism
    • Small-vessel occlusion (lacunar)
    • Stroke of other determined etiology
    • Stroke of undetermined etiology
  • Proper classification using TOAST helps clinicians determine the most effective prevention strategy, as the recurrence risk and optimal treatment differ significantly between subtypes 1.

Diagnosis and Classification

The diagnosis and classification of a stroke using the TOAST system involve a comprehensive evaluation of the patient's clinical features, brain imaging, cardiac evaluation, and vascular studies.

Treatment and Secondary Prevention

The treatment and secondary prevention strategies for each subtype of ischemic stroke are:

  • Large-artery atherosclerosis: antiplatelet therapy (aspirin 81-325 mg daily, clopidogrel 75 mg daily, or aspirin plus extended-release dipyridamole), statins, and risk factor modification.
  • Cardioembolic strokes: anticoagulation with warfarin (target INR 2-3) or direct oral anticoagulants like apixaban (5 mg twice daily), rivaroxaban (20 mg daily), or dabigatran (150 mg twice daily).
  • Small-vessel occlusion strokes: antiplatelet therapy and aggressive blood pressure control (target <130/80 mmHg) 2, 3, 4.

Related Questions

What is the recommended dual antiplatelet therapy (DAPT) regimen for acute ischemic stroke?
Should a 55-year-old patient with a history of Transient Ischemic Attack (TIA) in 2014, who underwent Patent Foramen Ovale (PFO) closure in 2019 and has controlled Hyperlipidemia (HLD) and Hypertension (HTN), continue taking aspirin (acetylsalicylic acid)?
What lifestyle modifications should a 34-year-old female patient (post-stroke patient) avoid after experiencing a cerebrovascular accident (CVA) or stroke?
What is the optimal acute and secondary prevention management for a 60‑year‑old pre‑diabetic patient presenting with a posterior‑circulation TIA due to left vertebral‑artery atherosclerosis, who improved after aspirin and clopidogrel?
How should I manage a 72‑year‑old woman with recent ischemic stroke on losartan, clopidogrel, atorvastatin, and aspirin who now has severe hypertension?
What is the etiology of a Cerebrovascular Accident (CVA) or Stroke?
Can a history of emotional trauma, autism spectrum disorder (ASD), bullying, and ostracism, combined with an unconventional upbringing and significant anxiety and depression, impact one's ability to form and maintain meaningful social connections?
What is a low dose magnesium intake?
What causes aphthous ulcers (canker sores)?
What is the diagnosis for a patient with a suspected Salter-Harris (Type 1 fracture of the growth plate) fracture of the distal fibular physis, presenting with tenderness over the lateral malleolus and potential ligamentous injury, based on Magnetic Resonance Imaging (MRI) findings?
What is the diagnosis and prognosis of a patient with a suspected Salter-Harris (growth plate fracture) type 1 fracture of the distal fibular physis, with bone marrow edema and no evidence of ligamentous injury?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.